These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Resorcinol congeners of dopamine derived from benzocycloheptene and indan. Cannon JG; Pease JP; Hamer RL; Ilhan M; Bhatnagar RK; Long JP J Med Chem; 1984 Feb; 27(2):186-9. PubMed ID: 6319700 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins. Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183 [TBL] [Abstract][Full Text] [Related]
7. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists. Arvidsson LE; Hacksell U; Johansson AM; Nilsson JL; Lindberg P; Sanchez D; Wikström H; Svensson K; Hjorth S; Carlsson A J Med Chem; 1984 Jan; 27(1):45-51. PubMed ID: 6418888 [TBL] [Abstract][Full Text] [Related]
8. [Peripheral dopaminergic receptor agonists as potential drugs in diseases of the circulatory system]. Kostowski W Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1448-51. PubMed ID: 2870482 [No Abstract] [Full Text] [Related]
9. Synthesis and pharmacological evaluation of aromatic dihydroxylated spiro[indan-1,3'-pyrrolidine] and spiro[indan-2,2'-pyrrolidine] derivatives. Sommerville R; Rosenberg HE; Crooks PA J Pharm Sci; 1985 May; 74(5):553-5. PubMed ID: 4020632 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam. Weinstock J; Ladd DL; Wilson JW; Brush CK; Yim NC; Gallagher G; McCarthy ME; Silvestri J; Sarau HM; Flaim KE J Med Chem; 1986 Nov; 29(11):2315-25. PubMed ID: 2878077 [TBL] [Abstract][Full Text] [Related]
11. C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor. Nichols DE; Jacob JN; Hoffman AJ; Kohli JD; Glock D J Med Chem; 1984 Dec; 27(12):1701-5. PubMed ID: 6502600 [TBL] [Abstract][Full Text] [Related]
12. Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine. Kaiser C; Dandridge PA; Garvey E; Hahn RA; Sarau HM; Setler PE; Bass LS; Clardy J J Med Chem; 1982 Jun; 25(6):697-703. PubMed ID: 6980283 [TBL] [Abstract][Full Text] [Related]
13. Solubilized receptors for [3H]dopamine (D3 binding sites) from canine brain. Davis A; Madras BK; Seeman P Biochem Pharmacol; 1982 Apr; 31(7):1183-7. PubMed ID: 7092913 [TBL] [Abstract][Full Text] [Related]
14. Conformational analogues of dopamine. Synthesis and pharmacological activity of (E)- and (Z)-2-(3,4-dihydroxyphenyl)cyclopropylamine hydrochlorides. Erhardt PW; Gorczynski RJ; Anderson WG J Med Chem; 1979 Aug; 22(8):907-11. PubMed ID: 40027 [TBL] [Abstract][Full Text] [Related]
15. Cardiotonic agents. Synthesis and inotropic activity of a series of isoquinolin-3-ol derivatives. Kanojia RM; Press JB; Lever OW; Williams L; McNally JJ; Tobia AJ; Falotico R; Moore JB J Med Chem; 1988 Jul; 31(7):1363-8. PubMed ID: 3385731 [TBL] [Abstract][Full Text] [Related]
16. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists. Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog. Lang WJ; Woodman OL Br J Pharmacol; 1982 Sep; 77(1):23-8. PubMed ID: 6982091 [TBL] [Abstract][Full Text] [Related]
18. N-Aralkyl substitution of 2-amino-5,6- and -6,7-dihydroxy-1,2,3,4-tetrahydronaphthalenes. 2. Derivatives of a hypotensive-positive inotropic agent. Stout DM; Gorczynski RJ J Med Chem; 1982 Mar; 25(3):326-8. PubMed ID: 7069709 [TBL] [Abstract][Full Text] [Related]